A two-part deep dive into one of the most important and contentious areas of the 340B program. While much of the 340B community’s attention has been focused on the contract pharmacy suits winding through the federal court system, there is other activity that the federal court system is grappling with that one could argue is equally or even more important. A federal appeals court is his hearing arguments challenging one of the 340B program’s bedrock principles—the definition of a “patient” eligible to receive 340B drugs. 340B Report takes a close look at the groundbreaking case’s influence over the government’s position on patient definition and its far-reaching implications.

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

*Sign up for news summaries and alerts from 340B Report

Site Footer